- HK$6.55bn
- HK$5.74bn
- CNY1.37bn
Brief: Lifetech Scientific Says Surechamtm Stent Graft Admitted To Nmpa Special Examination And Approval Procedure
Brief: Lifetech Scientific Expects Net Profit Attributable For Six Months Ended June 2026
Brief: Lifetech Scientific To Not Proceed With Major Deal
Brief: Lifetech Scientific To Buy 96.46% Of Starway Medical Technology
Brief: Lifetech Scientific Says Liu Jianxiong Resigns As Executive Director
Brief: LifeTech Scientific Corp Posts Full-Year Net Income Attributable Of RMB 147.8 Million
Brief: LifeTech Scientific Updates On Concave Supra-Arch Branched Stent-Graft System
Brief: Lifetech Scientific Gets Registration Approval For G-Iliac Tm Pro Iliac Artery Stent Graft System
Brief: LifeTech Scientific Says Ruan Xingmei Resigns As Executive Director
Brief: Lifetech Scientific's G-Branch Thoracoabdominal Artery Stent Graft System Approved By China NMPA
Brief: Lifetech Scientific Says Admission Of Innovative Medical Devices Into Special Examination, Others From NMPA
Brief: LifeTech Scientific's Unit To Invest RMB150 Mln In Affector Medtech
Brief: Lifetech Scientific Says Aortic Arch Stent Graft System Obtained Approval From Nmpa
Brief: FY Net Income Attributable RMB222.4 million
Brief: Lifetech Scientific Says Unit Subscribed For Principal-Protected Structured Deposits
Brief: LifeTech Scientific Says Ankura Aortic Stent Graft System Obtained Official Registration Approval
Brief: Lifetech Scientific Appoints Ruan Xingmei As Executive Director
Brief: LifeTech Scientific Corp Posts H1 Net Income Attributable RMB 205.6 Mln
Brief: Lifetech Scientific Says Unit Subscribed For Principal-Protected And Floating Income Structured Deposits